hematopoietic stem cell gene therapy lentiviral vector x-linked adrenoleukodystrophy 
x-linked adrenoleukodystrophy ald severe brain demyelinating disease boys caused deficiency ald protein adenosine triphosphate-binding cassette transporter encoded abcd1 gene ald progression can halted allogeneic hematopoietic cell transplantation hct initiated gene therapy trial two ald patients matched donors autologous cd34+ cells removed patients genetically corrected ex vivo lentiviral vector encoding wild-type abcd1 re-infused patients received myeloablative treatment span months follow-up detected polyclonal reconstitution % granulocytes monocytes t b lymphocytes expressing ald protein results strongly suggest hematopoietic stem cells transduced patients beginning months infusion genetically corrected cells progressive cerebral demyelination two patients stopped clinical outcome comparable achieved allogeneic hct thus lentiviral-mediated gene therapy hematopoietic stem cells can provide clinical benefits ald 
